收稿日期: 2026-02-13
网络出版日期: 2026-06-30
基金资助
山东省医药卫生科技发展计划项目(202303050713)
Exploring the mechanism of crocin in alleviating high glucose induced glomerular endothelial cell damage based on the IKKβ/NF⁃κB signaling pathway
Received date: 2026-02-13
Online published: 2026-06-30
目的 基于核因子κB抑制物激酶β(IKKβ)/核转录因子-κB(NF-κB)信号通路探讨藏红花素减轻高糖诱导的肾小球内皮细胞损伤的作用机制。 方法 以0、12.5、25、50、75 μmol/L藏红花素处理高糖诱导的人肾小球内皮细胞,通过CCK-8实验筛选藏红花素最佳作用浓度。肾小球内皮细胞随机分为正常组、渗透压对照组、高糖组、藏红花素组、佛波酯(PMA)组、藏红花素+PMA组,除正常组、渗透压对照组外其余各组以高糖诱导,与此同时用藏红花素和IKKβ/NF-κB信号通路激活剂PMA分组处理48 h。通过免疫荧光染色观察细胞骨架;通过CCK-8实验、Transwell实验、原位末端标记法(TUNEL)染色分别检测细胞活性、通透性与凋亡;测定细胞氧化应激与炎症相关因子水平;免疫印迹(WB)检测凋亡、紧密连接与IKKβ/NF-κB信号通路蛋白表达。 结果 与正常组、渗透压对照组相比,高糖组肾小球内皮细胞活性、超氧化物歧化酶(SOD)与谷胱甘肽过氧化物酶(GSH-Px)活性、occludin蛋白相对表达、闭锁蛋白1(ZO-1)与Bcl-2蛋白相对表达降低(P < 0.05),通透性、凋亡率、丙二醛(MDA)含量、白细胞介素(IL)-6与IL-1β水平、Bax蛋白相对表达、p-IKKβ/IKKβ、p-IκB-α/IκB-α、p-NF-κB p65/NF-κB p65升高(P < 0.05)。与高糖组相比,藏红花素组肾小球内皮细胞活性、SOD与GSH-Px活性、occludin蛋白相对表达、ZO-1与Bcl-2蛋白相对表达升高(P < 0.05),通透性、凋亡率、MDA含量、IL-6与IL-1β水平、Bax蛋白相对表达、p-IKKβ/IKKβ、p-IκB-α/IκB-α、p-NF-κB p65/NF-κB p65降低(P < 0.05);PMA组各指标变化趋势与藏红花素组相反(P < 0.05)。与藏红花素组相比,藏红花素+PMA组肾小球内皮细胞活性、SOD与GSH-Px活性、occludin蛋白相对表达、ZO-1与Bcl-2蛋白相对表达降低(P < 0.05),通透性、凋亡率、MDA含量、IL-6与IL-1β水平、Bax蛋白相对表达、p-IKKβ/IKKβ、p-IκB-α/IκB-α、p-NF-κB p65/NF-κB p65升高(P < 0.05)。 结论 藏红花素通过抑制IKKβ/NF-κB信号通路激活减轻高糖诱导的肾小球内皮细胞损伤。
关键词: 藏红花素; 核因子κB抑制物激酶β/核转录因子-κB; 高糖; 肾小球内皮细胞; 损伤
王洪云 , 张成才 , 王伟伟 . 基于IKKβ/NF-κB信号通路探讨藏红花素减轻高糖诱导肾小球内皮细胞损伤的作用机制[J]. 实用医学杂志, 2026 , 42(12) : 2208 -2215 . DOI: 10.3969/j.issn.1006-5725.2026.12.016
Objective To investigate the mechanism by which crocin alleviates high glucose-induced glomerular endothelial cell damage based on the inhibitor of nuclear factor kappa B kinase β (IKKβ)/nuclear transcription factor-κB (NF-κB) signaling pathway. Methods High glucose-induced human glomerular endothelial cells were treated with crocin at concentrations of 0, 12.5, 25, 50, and 75 μmol/L, and the optimal concentration of crocin was screened via the CCK-8 experiment. Glomerular endothelial cells were randomly assigned to the normal group, osmotic pressure control group, high glucose group, crocin group, phorbol ester (PMA) group, and crocin + PMA group. Except for the normal group and osmotic pressure control group, all the other groups were induced with high glucose and treated with crocin and the IKKβ/NF-κB signaling pathway activator PMA according to different groups for 48 hours. Immunofluorescence staining was employed to observe the cytoskeleton of the cells. The CCK-8 experiment, Transwell experiment, and TdT-mediated dUTP nick end labeling (TUNEL) staining were carried out to detect cell viability, permeability, and apoptosis, respectively. The oxidative stress and inflammation-related factors in the cells were measured. Western blot (WB) was utilized to detect the expression of proteins related to apoptosis, tight junctions, and the IKKβ/NF-κB signaling pathway. Results Compared with the normal group and the osmotic pressure control group, the high-glucose group exhibited a decrease in the activity of glomerular endothelial cells, the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), the relative expression of occludin protein, and the relative expressions of zonula occludens-1 (ZO-1) and Bcl-2 protein (P < 0.05). Meanwhile, it showed an increase in permeability, apoptosis rate, malondialdehyde (MDA) content, interleukin (IL)-6 and IL-1β levels, the relative expression of Bax protein, and the ratios of p-IKKβ/IKKβ, p-IκB-α/IκB-α, and p-NF-κB p65/NF-κB p65 (P < 0.05). Compared with the high-glucose group, the crocin group showed an increase in the activity of glomerular endothelial cells, the activities of SOD and GSH-Px, the relative expression of occludin protein, and the relative expressions of ZO-1 and Bcl-2 protein (P < 0.05). In addition, it had a decrease in permeability, apoptosis rate, MDA content, IL-6 and IL-1β levels, the relative expression of Bax protein, and the ratios of p-IKKβ/IKKβ, p-IκB-α/IκB-α, and p-NF-κB p65/NF-κB p65 (P < 0.05). The trend of changes in various indicators in the PMA group was opposite to that in the crocin group (P < 0.05). Compared with the crocin group, the crocin + PMA group showed a decrease in the activity of glomerular endothelial cells, the activities of SOD and GSH-Px, the relative expression of occludin protein, and the relative expressions of ZO-1 and Bcl-2 protein (P < 0.05). Moreover, it presented an increase in permeability, apoptosis rate, MDA content, IL-6 and IL-1β levels, the relative expression of Bax protein, and the ratios of p-IKKβ/IKKβ, p-IκB-α/IκB-α, and p-NF-κB p65/NF-κB p65 (P < 0.05). Conclusion Crocin alleviates the damage to glomerular endothelial cells induced by high glucose by inhibiting the activation of the IKKβ/NF-κB signaling pathway.
Key words: crocin; IKKβ/NF-κB; high glucose; glomerular endothelial cells; damage
| [1] | 高晶,赵锦,王凡,等. 不同频率血液透析滤过联合高通量血液透析治疗对糖尿病肾病维持性血液透析患者肾功能,微炎症状态及左心功能的影响[J]. 实用医学杂志, 2025, 41(21): 3398-3404. doi: 10.3969/j.issn.1006-5725.2025.21.015 . |
| [2] | LUO Y, ZHANG W, QIN G. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review)[J]. Mol Med Rep, 2024, 30(3): 156-168. doi: 10.3892/mmr.2024. 13280 . |
| [3] | WANG G, ZHAO J, ZHOU M,et al. Unveiling diabetic nephropathy: A novel diagnostic model through single-cell sequencing and co-expression analysis[J]. Aging (Albany NY), 2024, 16(13): 10972-10984. doi: 10.18632/aging.205982 . |
| [4] | ZHOU J, FRANCESCHINI N, TOWNLEY-TILSON W H D, et al. Nutritional Strategies against Diabetic Nephropathy: Insights from Animal Studies and Human Trials[J]. Nutrients, 2024, 16(12): 1918-1932. doi: 10.3390/nu16121918 . |
| [5] | LI Y, ZHANG J, ZHU Y. METTL14 derived from exosomes of M1 macrophages promotes high glucose-induced apoptosis, inflammation and oxidative stress in glomerular endothelial cells by mediating PAQR3 m6A modification[J]. Clin Exp Nephrol, 2024, 28(12): 1221-1231. doi: 10.1007/s10157-024-02536-0 . |
| [6] | XUE H Z, CHEN Y, WANG S D,et al. Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism[J]. J Diabetes Res, 2024, 2024: 5216113-5216138. doi: 10.1155/2024/5216113 . |
| [7] | WANG X, LIU M, LI X,et al. Utilizing molecular docking and cell validation to explore the potential mechanisms of lupenone attenuating the inflammatory response via NF-κB pathway[J]. Sci Rep, 2024, 14(1): 625-634. doi:10.1038/s41598-024- 51150-3 . |
| [8] | WEI T T, YANG L T, GUO F,et al. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy[J]. Acta Pharmacol Sin, 2021, 42(2): 252-263. doi: 10.1038/s41401-020-00520-4 . |
| [9] | LOTFY M, KHALAF A, ALBARGHOUTHY F,et al. Effects of Conocarpus lancifolius and crocin on superoxide dismutase and protein kinase B genes and protein expressions in diabetic rats[J]. PLoS One, 2025, 20(6): e0326676-e0326694. doi: 10.1371/journal.pone.0326676 . |
| [10] | MAFI A, MOKHTARI Z, HOSSEINI E,et al. Effect of Saffron (Crocus sativus) Supplementation on Oxidative Stress, Inflammatory Indices, and Renal and Liver Function Parameters in Patients With Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Clinical Trials[J]. Nutr Rev, 2025, 83(6): 971-987. doi: 10.1093/nutrit/nuae121 . |
| [11] | JAAFARINIA A, KAFAMI B, SAHEBNASAGH A,et al. Evaluation of therapeutic effects of crocin in attenuating the progression of diabetic nephropathy: A preliminary randomized triple-blind placebo-controlled trial[J]. BMC Complement Med Ther, 2022, 22(1): 262-270. doi: 10.1186/s12906-022-03744-5 . |
| [12] | ZHANG J, ZHAO X, ZHU H,et al. Crocin protects the renal tubular epithelial cells against high glucose-induced injury and oxidative stress via regulation of the SIRT1/Nrf2 pathway[J]. Iran J Basic Med Sci, 2022, 25(2): 193-197. doi: 10.22038/IJBMS.2022. 51597.11708 . |
| [13] | HASSAN M H, SALAMA S A, ISMAIL R S. Targeting NF-kappa B/proinflammatory cytokines/TGF-β/TIMP-1 pathway by crocin enhances recovery from hepatic fibrosis in rats[J]. Sci Rep, 2025, 16(1): 2072-2081. doi: 10.1038/s41598-025-32672-w . |
| [14] | 王延海, 张雷明, 冯艳艳. 大黄素改善高糖条件中人肾小球血管内皮细胞炎症,氧化应激及凋亡作用的研究[J]. 中国临床药理学杂志, 2023, 39(10): 1422-1426. doi: 10.13699/j.cnki. 1001-6821.2023.10.012 . |
| [15] | CHEN M, LIN X, ZHANG L,et al. Effects of nuclear factor-κB signaling pathway on periodontal ligament stem cells under lipopolysaccharide-induced inflammation[J]. Bioengineered, 2022, 13(3): 7951-7961. doi: 10.1080/21655979.2022. 2051690 . |
| [16] | WU X Q, ZHAO L, ZHAO Y L,et al. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota[J]. Pharm Biol, 2024, 62(1): 423-435. doi: 10.1080/13880209.2024.2351946 . |
| [17] | HUSHMANDI K, KLIONSKY D J, FARAHANI N, et al. Regulation of pyroptosis in diabetic nephropathy by long non-coding and circular RNAs[J]. Clin Exp Med, 2025, 25(1): 208-239. doi: 10.1007/s10238-025-01740-w . |
| [18] | M?YNARSKA E, BU?AWSKA D, CZARNIK W,et al. Novel Insights into Diabetic Kidney Disease[J]. Int J Mol Sci, 2024, 25(18): 10222-10245. doi: 10.3390/ijms251810222 . |
| [19] | HUANG M, CHANG J, LIU Y, et al. Apelin/APJ alleviates diabetic nephropathy by improving glomerular endothelial cells dysfunction via SIRT3?KLF15[J]. Mol Med Rep, 2025, 31(5): 122-133. doi: 10.3892/mmr.2025.13487 . |
| [20] | YANG Y, WANG Y, ZHOU Y,et al. Tirzepatide alleviates oxidative stress and inflammation in diabetic nephropathy via IL-17 signaling pathway[J]. Mol Cell Biochem,2025, 480(2): 1241-1254. doi: 10.1007/s11010-024-05066-1 . |
| [21] | GHAVIDEL F, AMIRI H, TABRIZI M H, et al. The Combinational Effect of Inulin and Resveratrol on the Oxidative Stress and Inflammation Level in a Rat Model of Diabetic Nephropathy[J]. Curr Dev Nutr, 2023, 8(1): 102059-102070. doi: 10.1016/j.cdnut.2023.102059 . |
| [22] | DASTAN M, RAJAEI Z, SHARIFI M, et al. Crocin Improves Cognitive Impairment in LPS-treated Rats through Anti-Apoptotic, Anti-Inflammatory, and Antioxidant Activities[J]. Mol Neurobiol, 2025, 62(5): 5804-5815. doi: 10.1007/s12035-024-04638-y . |
| [23] | ZIANI A, BEKKOUCH O, OUAHHOUD S,et al. Phytochemistry, Biological Activities, Molecular Mechanisms, and Toxicity of Saffron (Crocus sativus L.): A Comprehensive Overview[J]. Antioxidants (Basel), 2025, 14(12): 1433-1478. doi: 10.3390/antiox14121433 . |
| [24] | CHEN W, SU J, LIU Y,et al. Crocin Ameliorates Diabetic Nephropathy through Regulating Metabolism, CYP4A11/PPARγ, and TGF-β/Smad Pathways in Mice[J]. Curr Drug Metab, 2023, 24(10): 709-722. doi: 10.2174/011389200225792823103111 3337 . |
| [25] | MOHAMMADI Y, ZANGOOEI M, ZARDAST M, et al. The effect of crocin and losartan on TGF-β gene expression and histopathology of kidney tissue in a rat model of diabetic nephropathy[J]. Avicenna J Phytomed, 2023, 13(2): 189-199. doi: 10. 22038/AJP.2022.21414 . |
| [26] | ZHANG R, QIN L, SHI J. MicroRNA?199a?3p suppresses high glucose?induced apoptosis and inflammation by regulating the IKKβ/NF?κB signaling pathway in renal tubular epithelial cells[J]. Int J Mol Med, 2020, 46(6): 2161-2171. doi: 10.3892/ijmm.2020.4751 . |
| [27] | WANG Y, LI H, JIANG S,et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation[J]. Kidney Int, 2024, 106(2): 226-240. doi: 10.1016/j.kint.2024.04.016 . |
/
| 〈 |
|
〉 |